Keywords: دی دی آمین; HIV; Didanosine; Non-cirrhotic portal hypertension; Purine analog;
مقالات ISI دی دی آمین (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: دی دی آمین; Didanosine; Bovine serum albumin; Polysorbate 80; Biodistribution studies;
Surface amplification of pencil graphite electrode with polypyrrole and reduced graphene oxide for fabrication of a guanine/adenine DNA based electrochemical biosensors for determination of didanosine anticancer drug
Keywords: دی دی آمین; Adenine-guanine based sensor; Didanosine; Polypyrrole; Pencil graphite electrode;
Predicting CD4 count changes among patients on antiretroviral treatment: Application of data mining techniques
Keywords: دی دی آمین; CD4 count change; Antiretroviral treatment; Computational methods; Random Forest; Neural Network; J48, Decision tree; ABC; Abacavir; ddI; Didanosine; d4T; Stavudin; EFV; Efavirenz; FTC; Emotricitabine; LPV/r; Lopinavir/ritonavir; NFV; Nelfinavir; NNRTI; N
Didanosine-loaded chitosan microspheres optimized by surface-response methodology: A modified “Maximum Likelihood Classification” approach formulation for reverse transcriptase inhibitors
Keywords: دی دی آمین; Didanosine; Microspheres; Chitosan; Sodium tripolyphosphate; Surface-response methodology; Reverse transcriptase inhibitors; Pharmacotherapy
Epidemiology and impact of HIV coinfection with Hepatitis B and Hepatitis C viruses in Sub-Saharan Africa
Keywords: دی دی آمین; 3TC; Lamivudine; AOR; Adjusted Odds Ratio; ADV; adefovir; ALT; alanine transaminase; Anti-HBcAb; antibody to Hepatitis B core antigen; Anti-HBeAb; antibody to Hepatitis B e-antigen; Chronic hepatitis B; persistence of HBsAg >6months; d4T; Stavudine; ddI;
Anti-HIV efficacy and biodistribution of nucleoside reverse transcriptase inhibitors delivered as squalenoylated prodrug nanoassemblies
Keywords: دی دی آمین; Squalenoylation; Nanoassemblies; Prodrug; Didanosine; Zalcitabine
Monolayered multipolymeric buccal films with drug and polymers of opposing solubilities for ARV therapy: Physico-mechanical evaluation and molecular mechanics modelling
Keywords: دی دی آمین; Didanosine; Buccal; Films; Co-blended polymers; Physico-mechanical properties; Static lattice atomistic simulations
The role of nucleoside reverse transcriptase inhibitors usage in the incidence of hyperlactatemia and lactic acidosis in HIV/AIDS patients
Keywords: دی دی آمین; Nucleoside analogs; Didanosine; Stavudine; Hyperlactatemia; Lactic acidosis
Preparation of gastro-resistant pellets containing chitosan microspheres for improvement of oral didanosine bioavailability
Keywords: دی دی آمین; Didanosine; Pellets; Gastro-resistance; Coating; Microspheres; Chitosan
Analysis of in vivo absorption of didanosine tablets in male adult dogs by HPLC
Keywords: دی دی آمین; Didanosine; On-line solid phase extraction; HPLC; Male dogs
E17A mutation in HIV-1 Vpr confers resistance to didanosine in association with thymidine analog mutations
Keywords: دی دی آمین; HIV-1; Vpr; Drug resistance; Didanosine;
High frequency of antiviral drug resistance and non-B subtypes in HIV-1 patients failing antiviral therapy in Cuba
Keywords: دی دی آمین; ART; antiretroviral therapy; CI; confidence interval; NRTI; nucleoside reverse transcriptase inhibitor; NNRTI; non-nucleoside RTI; PI; protease inhibitor; FCR; full-class resistance; CRF; circulating recombinant form; HIV; human immunodeficiency virus; MD
Research ArticleThe role of nucleoside and nucleotide analogues in nodular regenerative hyperplasia in HIV-infected patients: A case control study
Keywords: دی دی آمین; NRH; nodular regenerative hyperplasia; NCPH; non-cirrhotic portal hypertension; HIV; human immunodeficiency virus; ddI; didanosine; IQR; interquartile range; ART; antiretroviral treatment; HAART; highly active antiretroviral treatment; BMI; body mass inde
Selection and Characterization of Suitable Lipid Excipients for use in the Manufacture of Didanosine-Loaded Solid Lipid Nanoparticles and Nanostructured Lipid Carriers
Keywords: دی دی آمین; Didanosine; Precirol® ATO 5; Transcutol® HP; Preformulation; Polymorphism; Crystallinity; Calorimetry (DSC); Xâray diffractometry; Solid lipid nanoparticles (SLNs); Nanostructured lipid carriers (NLCs);
A new nanomedicine based on didanosine glycerolipidic prodrug enhances the long term accumulation of drug in a HIV sanctuary
Keywords: دی دی آمین; Antiviral activity; Didanosine; In vivo experiments; Liposomes; Prodrug
Simultaneous determination of didanosine and its amino acid prodrug, valdidanosine by hydrophilic interaction chromatography coupled with electrospray ionization tandem mass spectrometry: Application to a pharmacokinetic study in rats
Keywords: دی دی آمین; Ultra-performance liquid chromatography–tandem mass spectrometry; Didanosine; Valdidanosine; Solid-phase extraction; Hydrophilic interaction; Pharmacokinetic study
Didanosine Polymorphism in a Supercritical Antisolvent Process
Keywords: دی دی آمین; supercritical antisolvent crystallization; solidâstate NMR; polymorphism; didanosine;
Self-assembled drug delivery systems: Part 3. In vitro/in vivo studies of the self-assembled nanoparticulates of cholesteryl acyl didanosine
Keywords: دی دی آمین; Degradation; Derivative; Didanosine; Nanoparticulates; Prodrugs; Self-assembly
Correlation of epidermal nerve fiber density with pain-related evoked potentials in HIV neuropathy
Keywords: دی دی آمین; HIV; human immunodeficiency virus; NDS; neuropathy deficit score; NSS; neuropathy symptoms score; PREP; pain-related evoked potentials; HAART; high active antiretroviral therapy; ddI; didanosine; SNC; standard nerve conduction; NCV; nerve conduction veloc
Mannosylated gelatin nanoparticles bearing an anti-HIV drug didanosine for site-specific delivery
Keywords: دی دی آمین; Gelatin nanoparticles; Mannose; Didanosine; Anti-HIV; Mannosylated nanoparticles
Morphological transformation of self-assembled nanostructures prepared from cholesteryl acyl didanosine and the optimal formulation of nanoparticulate systems: Effects of solvents, acyl chain length and poloxamer 188
Keywords: دی دی آمین; Bilayers; Cholesteryl derivatives; Didanosine; Drug delivery; Nanoribbons; Nanotubes; Poloxamer; Tetrahydrofuran; Self-assembly; Vesicles
Identification and characterization of new impurity in didanosine
Keywords: دی دی آمین; Didanosine; Impurities; Isolation; Preparative HPLC; Characterization
Liposomal formulation of a glycerolipidic prodrug for lymphatic delivery of didanosine via oral route
Keywords: دی دی آمین; Glycerolipidic prodrug; DSC; XRDT; Liposomes; Didanosine
Chronic Hepatitis C in the Human Immunodeficiency Virus-Infected Patient: Management Strategies
Keywords: دی دی آمین; ACTG; Acquired Immunodeficiency Syndrome Clinical Trials Group; APRICOT; Acquired Immunodeficiency Syndrome Pegasys Ribavirin International Coinfection Trials; AZT; zidovudine; CD4; human immunodeficiency virus helper cell count; ddI; didanosine; d4T; sta
An additive/substractive genotypic score as a determinant of the virological response to didanosine in HIV-1 infected patients
Keywords: دی دی آمین; HIV drug resistance; Didanosine; Algorithm; Nucleoside RT Inhibitors;
Genotypic resistance analyses in nucleoside-pretreated patients failing an indinavir containing regimen: results from a randomized comparative trial: (Novavir ANRS 073)
Keywords: دی دی آمین; PI; protease inhibitor; AZT; zidovudine; d4T; stavudine; 3TC; lamivudine; ddI; didanosine; ddC; zalcitabine; IDV; indinavir; NFV; nelfinavir; APV; amprenavir; RT; reverse transcriptase; PR; protease; HIV; human immunodeficiency virus; M8; nelfinavir hydro
Development and validation of a HPLC-UV method for the determination in didanosine tablets
Keywords: دی دی آمین; Didanosine; Validation; HPLC-UV; tablets;
Effets indésirables induits par les traitements antirétroviraux
Keywords: دی دی آمین; ABC; abacavir; APV; amprénavir; ARV; antiretroviral; ASAT; aspartate aminotransférase; ATZ; atazanavir; AZT; zidovudine; ddI; didanosine; d4T; stavudine; EFV; éfavirenz; EI; effet indésirable; FTC; emtricitabine; HDL; lipoprotéine de haute densité;
Pharmacokinetics of antivirals in neonate
Keywords: دی دی آمین; Antivirals; Neonate; Pharmacokinetics; Zidovudine; Didanosine; Stavudine; Lamivudine; Nelfinavir; Nevirapine; Acyclovir; Ganciclovir; Pleconaril;
Simultaneous determination of the HIV nucleoside analogue reverse transcriptase inhibitors lamivudine, didanosine, stavudine, zidovudine and abacavir in human plasma by reversed phase high performance liquid chromatography
Keywords: دی دی آمین; Nucleoside reverse transcriptase inhibitors; Abacavir; Didanosine; Lamivudine; Stavudine; Zidovudine; HPLC; HIV;
Treatment-limiting toxicities associated withnucleoside analogue reverse transcriptase inhibitor therapy: A prospective, observational study
Keywords: دی دی آمین; nucleoside analogue reverse transcriptase inhibitor toxicity; stavudine; zidovudine; lamivudine; didanosine; abacavir; tenofovir; HIV-1 infection; AIDS; highly active antiretroviral therapy;
Pharmacotherapy of perinatal HIV
Keywords: دی دی آمین; Anti-HIV agents; Breast feeding; Didanosine; Disease transmission; Efavirenz; Female; HIV infections; Human; Indinavir; Infant; newborn; Lamivudine; Nelfinavir; Nevirapine; Pharmacokinetics; Pregnancy; Ritonavir; Saquinavir; Stavudine; Zidovudine;